Previous studies have shown that the compound can improve hepatic steatosis and inflammation, reduce serum transaminases, and inhibit JNK activation in liver tissue of NASH mice (Liu et al., 2014). The gene discussed is MAPK8; the disease is metabolic dysfunction-associated steatohepatitis.